Malignant Hyperthermia - References
Allen G et al: Safety of general anesthesia in patients previously tested negative for malignant hypertheria susceptibility. Anesthesiology 72:619, 1990
Birmingham P et al: Isolated postoperative myoglobinuria in a pediatric outpatient. Anesth Analg 69:846, 1989
Brown, A, Harshad G, Litman, R. Malignant Hyperthermia and the Muscular Dystrophies. MHAUS. http://medical.mhaus.org/index.cfm/fuseaction/Content.Display/PagePK/MuscularDystrophies.cfm
Denborough MA and Lovell RRH: Anaesthetic deaths in a family. Lancet 2:45, 1960
Durbin CG et al: Cardiovascular effect of intravenous dantrolene alone and in the presence of verapamil. Anesthesiology 59(3):A227, 1983
Hannallah RS and Kaplan RF: Jaw relaxation after a halothane/succinylcholine swquence in children. Anesthesiology 81:99, 1994
Heffron J et al: Current views of the molicular basis of the malignant hyperthermia syndrome. Acta Anaesth Belg 41:73, 1990
Hopkins PM: Malignant hyperthermia: advances in clincal management and diagnosis. Br J Anaesth 85:118-28, 2000
Iazzo P et al: Enhanced mobilization of intracellular Ca++ induced by halothane in hepatocytes isolated from swine susceptible to malignant hyperthermia. Anesthesiology 74:531, 1991
Kaplan RF: Malignant Hyperthermia. 1993 Annual Refresher Course Lectures, ASA, Inc, 1993
Krivosic-Horber R: Treatment of the acute episode. Acta Anaesth Belg 41:83, 1990
Larach M et al: Standardization of the caffeine halothane muscle contracture test. Anesth Analg 69"511, 1989
Larach MG and Muldoon SM: North American malignant hyperthermia registry clinical and research mission. ASA Newsletter 61(4):16-18, 1997
Leary NP et al: Masseteric muscle spasm as a normal response to suxamethonium. Br J Anaesth 64:488, 1990
Levitt RC et al: Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q. Genomics 14:562-566, 1992
Levitt RC et al: Molecular genetics and malignant hyperthermia. Anesthesiology 75:1, 1991
Littleford J et al: Masseter muscle spasm in children: implications of continuing the truggering anesthetic. Anesth Analg 72:151, 1991
Lopez JR, Alamo L et al: Intracellular ionized calcium concentrations in muscles from humans with malignant hyperthermia. Muscle Nerve 8:355, 1985
MacKenzie AE et al: A comparison of the caffeine halothane muscle contracture test with the molecular genetic diagnosis of malignant hyperthermia. Anesthesiology 75:4, 1991
MacLennan DH et al: Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 343:559, 1990
McCarthy T et al: Recent developments in the molecular genetics of malignant hyperthermia: implications for future diagnosis at the DNA level. Acta Anaesth Belg 41:107, 1990
McCarthy TV et al: Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 343:562, 1990
Melton A et al:Malignant hyperthermia in humans - standardization of contracture testing protocol. Anesth Analg 69:437, 1989
Morther W: Malignant hyperthermia: relation to other diseases. Acta Anaesth Belg 41:119, 1990
Nelson T: Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses. Anesthesiology 73:449, 1990
O'Flynn RP et al: Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis. Anesthesiology 80:1228, 1994
Rosenberg H: Malignant hyperthermia: the disease of anesthesia, in 50th Annual Refresher Course Lectures and Clincial Update Program, American Society of Anesthesiologists, 1999
Rosenberg H: Standards for halothane/caffeine contracture test. Anesth Analg 69:429, 1989
Rosenberg H et al: Testing for Malignant Hyperthermia. Anesthesiology 96:232-7, 2002
Rosenberg H. Malignant Hyperthermia Slide Show at MHAUS, 2004
Saltzman LS et al: Hyperkalemia and cardiovascular collapse after verapamil and dantrolene administration in swine. Anesth Analg 63:473, 1984
Schuster F et al: An In-Vivo Metabolic Test for Detecting Malignant Hyperthermia Susceptibility in Humans: A Pilot Study. Anesth Analg 107:909-914, 2008
Urwyler A et al: Genetic effects on the variability of the halothane and caffeine muscle contracture tests. Anesthesiology 80:1287, 1994
Wedel D et al: Desflurane is a trigger of malignant hyperthermia in susceptivle swine. Anesthesiology 74:508, 1991
Wilhoit R et al: Possible malignant hyperthermia in a 7-week-old infant. Anest Analg 68:888, 1989
See also: Gordon: Malignant Hyperthermia Presentation, February, 2005